[1]
Sandberg A, Ragnarsson G, Jonsson UE, Sjrgren J. Design
of a New Multiple-Unit Controlled-Release Formulation of
Metoprolol - Metoprolol CR. Eur J Clin Pharmacol 1988; 33(Suppl S3-7).
[2]
Ibrahim MA, El-badry M. Formulation of immediate release pellets containing famotidine solid dispersions. Saudi Pharm J 2014; 22(2): 149-56.
[3]
Yuen KH, Deshmukh AA, Newton JM, Short M, Melchor R. Gastrointestinal transit and absorption of theophylline from a multiparticulate controlled release formulation. Int J Pharm 1993; 97: 61-7.
[4]
Dukic-Ott A, Thommes M, Remon JP, Kleinebudde P, Vervaet C. Production of pellets via extrusion - spheronisation without the incorporation of microcrystalline cellulose : A critical review. Eur J Pharm Biopharm 2009; 71: 38-46.
[5]
Levina M, Rajabi-siahboomi ALIR. The influence of excipients on drug release from hydroxypropyl methylcellulose matrices. J Pharm Sci 2004; 93(11): 2746-54.
[6]
Robinson PC, Horsburgh S. Gout: Joints and beyond, epidemiology, clinical features, treatment and co-morbidities. Maturitas 2014; 78(4): 245-51.
[7]
Wang J, Kan S, Chen T, Liu J. Application of quality by design (QbD) to formulation and processing of naproxen pellets by extrusion - spheronization. Pharm Dev Technol 2014; 20(2): 246-56.
[8]
Pallagi E, Ambrus R, Szabó-révész P, Csóka I. Adaptation of the Quality by Design concept in early pharmaceutical development of an intranasal nanosized formulation. Int J Pharm 2015; 491(1-2): 384-92.
[9]
Yan H, Zhang S, He J, Liu J. Application of ethyl cellulose, microcrystalline cellulose and octadecanol for wax based floating solid dispersion pellets. Carbohydr Polym 2016; 148: 143-52.
[10]
Ovensten A, Benbow J. Effects of die geometry on the extrusion of clay like material. Trans Br Ceram Soc 1968; 67: 543-67.
[11]
Fielden KE, Newton JM. Extrusion and extruders. inEncyclopedia of Pharmaceutical Technology Third. Swarbrick J, Boylan J, editors. . New York and, Basel:: Marcel Dekker 1992; pp. 395-442.
[12]
Newton JM. The preparation of spherical granules by extrusion / spheronisation. STP Pharma 1990; 6: 396-8.
[13]
Yan X, He H, Meng J, Zhang C, Hong M, Tang X. Preparation of lipid aspirin sustained-release pellets by solvent-free extrusion / spheronization and an investigation of their stability. Drug Dev Ind Pharm 2012; 38(103): 1221-9.
[14]
Basit AW, Newton JM, Lacey LF. Formulation of ranitidine pellets by extrusion-spheronization with little or No microcrystalline cellulose. Pharm Dev Technol 1999; 4(4): 499-505.
[15]
Sonaglio D, Bataille B, Ortigosa C, Jacob M. Factorial design in the feasibility of producing Microcel MC 101 pellets by extrusion / spheronization. Int J Pharm 1995; 115: 53-60.
[16]
Patel N, Thakkar V, Moradiya P, Gandhi T, Gohel M. Optimization of curcumin loaded vaginal in-situ hydrogel by box- behnken statistical design for contraception. J Drug Deliv Sci Technol 2015; 29: 55-68.
[17]
Gurram RK, Gandra S, Shastri NR. Design and optimization of disintegrating pellets of MCC by non-aqueous extrusion process using statistical tools. Finance Res Lett 2016; 84: 146-56.
[18]
Lutchman D, Dangor CM, Perumal D. Formulation of rate-modulating pellets for the release of ibuprofen : An extrusion-spheronization process. J Microencapsul 2005; 22(6): 643-59.
[19]
Lilly E. Development of a multiple unit pellet formulation for a weakly basic drug. Drug Dev Ind Pharm 2007; 33: 341-9.
[20]
Goyanes A, Souto C. A comparison of chitosan-silica and sodium starch glycolate as disintegrants for spheronized extruded microcrystalline cellulose pellets. Drug Dev Ind Pharm 2011; 37(7): 825-31.
[21]
Gryczová E, Dvořáčková K, Rabišková M. Evaluation of pellet friability Čes slov Farm 2009; 58: 9-13.
[22]
Haripriya M. Development of validated UV spectrophotometric methods for the simultaneous estimation of febuxostat and diclofenac potassium in tablet dosage form utilising simultaneous equation and absorbance ratio method. Int J Pharma Bio Sci 2013; 4(3): 134-8.
[23]
Bagga P. A simple UV spectrophotometric method for the determination of febuxostat in bulk and pharmaceutical formulations. Int J Pharm Sci Res 2011; 2(10): 2655-9.
[24]
Modi N. Development and validation of spectrophotometric method for simultaneous estimation of diclofenac potassium and febuxostat in tablet dosage forms. Pharma Sci Monitor 2012; 3(3): 268-78.
[25]
Buskirk GA Van , Shah V, Yacobi A. PQRI Workshop
report: application of IVIVC in formulation development. Dissolution Technol. 2014; 51-8.
[26]
Cardot J, Beyssac E, Alric M. In Vitro - In Vivo Correlation : Importance of Dissolution in IVIVC Level B. Dissolut Technol 2007; 14(1): 15-9.
[27]
Ishak RA, Mortada ND, Zaki NM. El-Shamy Ael-H, Awad GA. Impact of microparticle formulation approaches on drug burst release : a level A IVIVC. J Microencapsul 2014; 31: 674-84.
34
2
1